Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

SHE:300832 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	4,502	4,527	3,920	3,040	2,539	2,190
Other Revenue	6.81	8.2	9.91	6.47	6.17	5.12
Revenue	4,509	4,535	3,930	3,047	2,545	2,195
Revenue Growth (YoY)	5.47%	15.42%	28.97%	19.70%	15.97%	30.53%
Cost of Revenue	1,351	1,267	1,064	906.2	734.3	500.87
Gross Profit	3,159	3,269	2,866	2,141	1,811	1,694
Selling, General & Admin	877.62	839.96	736.09	463.67	537.29	503.63
Research & Development	486.42	453.59	366.05	317.71	215.05	150.58
Other Operating Expenses	39.63	16	15.25	12.49	8.57	5.72
Operating Expenses	1,429	1,336	1,128	807.89	753.54	671.47
Operating Income	1,730	1,933	1,739	1,333	1,058	1,023
Interest Expense	-0.47	-0.42	-0.43	-0.27	-0.15	-
Interest & Investment Income	100.18	108.16	89.8	66.76	56.6	59.74
Currency Exchange Gain (Loss)	30.95	18.64	17.71	68.98	-31.3	-27.1
Other Non Operating Income (Expenses)	13.44	-3.37	-2.83	-2.23	-1.43	2.5
EBT Excluding Unusual Items	1,874	2,056	1,843	1,466	1,081	1,058
Gain (Loss) on Sale of Investments	23.37	28.94	18.55	15.62	18.76	0.97
Gain (Loss) on Sale of Assets	0.04	0.04	0.05	0.62	0.1	-0.25
Asset Writedown	-1.24	-0.43	-1.52	-1.52	-1.86	-0.63
Other Unusual Items	31.88	9.1	33.23	20.38	37.24	38.89
Pretax Income	1,928	2,093	1,893	1,501	1,136	1,097
Income Tax Expense	231.73	264.74	239.41	173.28	161.83	157.61
Net Income	1,696	1,828	1,654	1,328	973.7	939.15
Net Income to Common	1,696	1,828	1,654	1,328	973.7	939.15
Net Income Growth	-6.11%	10.57%	24.53%	36.38%	3.68%	21.55%
Shares Outstanding (Basic)	786	786	785	785	784	750
Shares Outstanding (Diluted)	786	786	786	786	786	750
Shares Change (YoY)	0.00%	-0.01%	-0.07%	0.04%	4.76%	6.61%
EPS (Basic)	2.16	2.33	2.11	1.69	1.24	1.25
EPS (Diluted)	2.16	2.33	2.10	1.69	1.24	1.25
EPS Growth	-6.12%	10.59%	24.61%	36.32%	-1.03%	14.02%
Free Cash Flow	814.54	917.24	1,096	559.17	430.28	721.84
Free Cash Flow Per Share	1.04	1.17	1.40	0.71	0.55	0.96
Dividend Per Share	1.300	1.300	1.000	0.700	0.600	1.316
Dividend Growth	30.00%	30.00%	42.86%	16.67%	-54.40%	-
Gross Margin	70.05%	72.07%	72.93%	70.26%	71.15%	77.18%
Operating Margin	38.36%	42.61%	44.24%	43.74%	41.55%	46.59%
Profit Margin	37.62%	40.31%	42.08%	43.58%	38.25%	42.79%
Free Cash Flow Margin	18.06%	20.22%	27.89%	18.35%	16.90%	32.89%
EBITDA	1,916	2,110	1,888	1,445	1,151	1,102
EBITDA Margin	42.49%	46.52%	48.05%	47.42%	45.23%	50.20%
D&A For EBITDA	185.86	177.54	149.58	111.87	93.64	79.15
EBIT	1,730	1,933	1,739	1,333	1,058	1,023
EBIT Margin	38.36%	42.61%	44.24%	43.74%	41.55%	46.59%
Effective Tax Rate	12.02%	12.65%	12.65%	11.54%	14.25%	14.37%
Revenue as Reported	4,509	4,535	3,930	3,047	2,545	2,195
Advertising Expenses	-	73.75	58.54	34.34	20.25	2.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.